The Silent Pandemic: Unpacking Antibiotic Resistance in South African Primary Care
"A deep dive into how knowledge, attitudes, and perceptions of ABR among prescribers could be the key to curbing its spread."
Antibiotic resistance (ABR) represents a significant threat to global health, jeopardizing our ability to treat common infections. In South Africa, as in many other parts of the world, the inappropriate use of antibiotics in primary care settings is a major driver of this resistance. Understanding the knowledge, attitudes, and perceptions of healthcare providers who prescribe these medications is crucial for developing effective strategies to promote responsible antibiotic use.
A recent study delved into the minds of South African primary care prescribers to assess their understanding of ABR, their attitudes towards prescribing practices, and their perceptions of patient expectations and other influencing factors. The findings offer valuable insights into the complexities of antibiotic stewardship in this specific context.
This article breaks down the key findings of this research, exploring the challenges and opportunities for improving antibiotic prescribing practices in South Africa. By understanding the perspectives of those on the front lines of healthcare, we can work towards more effective interventions to combat the growing threat of antibiotic resistance and protect public health.
Global Political Response
Antimicrobial resistance has attracted strong political attention. The 2024 United Nations General Assembly high-level meeting committed to reducing mortality and improving antibiotic use. This commitment highlights the international priority placed on addressing resistance and antibiotic stewardship.
Stewardship and Diagnostics
Antibiotic stewardship is the effort to optimize how antibiotics are used and is considered a core strategy for combating antimicrobial resistance. Effective stewardship depends on rapid and accurate diagnostics that minimize unnecessary antibiotic use. The CDC reported that its 2023 guidance supported implementation of both antimicrobial and diagnostic stewardship in health care.
A Longstanding Threat
Antimicrobial resistance is not a new health threat. Historical accounts describe resistance as having challenged infectious-disease treatment since the discovery and widespread use of modern antimicrobials. The Hospitalist reports that resistance was recognized soon after penicillin became widely used in the 1940s.
Decoding Prescriber Perceptions: Knowledge vs. Pressure
The study, which surveyed a diverse group of primary healthcare providers in South Africa, revealed a complex landscape of knowledge, attitudes, and perceptions surrounding ABR. A significant majority (95.8%) of prescribers recognized ABR as a major problem in South Africa. However, a concerning 66.5% reported feeling pressure from patients to prescribe antibiotics, even when they didn't believe they were necessary. This highlights a key tension between prescribers' awareness of the ABR issue and the perceived need to satisfy patient demands.
- Narrow-spectrum antibiotics: Those with higher knowledge scores were more likely to favor narrow-spectrum antibiotics over broad-spectrum options when appropriate (adjusted odds ratio (aOR) 1.29, 95% confidence interval (CI) 1 - 1.65).
- Patient education: They were also more inclined to explain disease features that should prompt follow-up as an alternative to prescribing antibiotics (aOR 1.47, 95% CI 1.058 - 2.04).
- Avoiding unnecessary prescriptions: Notably, they were less likely to believe that antibiotics are harmless even when not needed, and therefore less likely to prescribe them unnecessarily (aOR 0.57, 95% CI 0.38 - 0.84).
Evidence from South African Primary Care
Recent South African research is examining antibiotic prescribing and resistance through several complementary approaches. A study of Enterobacterales places carbapenem resistance from agricultural, environmental, and clinical origins in a global context, while African reviews report resistance trends among pathogens including Klebsiella pneumoniae, Escherichia coli, Shigella species, Vibrio cholerae, and Salmonella species. Another multicentre point-prevalence study is testing 13 WHO AWaRe classification-based quality indicators for acute respiratory tract infections in South African primary healthcare.
Misuse and the Innovation Gap
Antimicrobial resistance is widely described as being driven by antibiotic misuse and overuse across human and animal sectors. The resulting rise of multidrug-resistant pathogens creates substantial challenges for healthcare systems. At the same time, the search for new antibiotics remains pressing, while pharmaceutical-industry investment in new antibiotic research has been described as continuously insufficient.
Resistance as a Persistent Medical Challenge
The emergence of antibiotic resistance has remained a difficult problem for medicine from the introduction of the first antibiotic to the present day. This historical continuity shows that resistance is not limited to a single period of antimicrobial development. It has accompanied the use of conventional antibiotics throughout modern medical practice.
Empowering Prescribers: Education and Beyond
The study underscores the need for ongoing education and support for primary care prescribers in South Africa. By equipping them with the knowledge and tools to make informed prescribing decisions, we can empower them to resist patient pressure and prioritize responsible antibiotic use. Further interventions should focus on improving communication strategies to address patient expectations, promoting the use of narrow-spectrum antibiotics when appropriate, and ensuring access to diagnostic tests to guide treatment decisions. Ultimately, a multi-faceted approach is essential to tackling the complex challenge of antibiotic resistance and safeguarding the effectiveness of these life-saving medications for future generations.
Precision in Antibiotic Use
Antibiotic stewardship promotes the proficient use of selected antibiotics for the precise source of infection, at the appropriate quantity, form, and duration. The stated aim is to improve treatment outcomes while reducing resistance, toxicity, bacterial elimination problems, and adverse activities. Current discussion of antibiotic stewardship also includes evolving antimicrobial susceptibility patterns.
Protecting Future Effectiveness
Antimicrobial stewardship is designed as an organizational or system-wide healthcare strategy. It promotes, improves, monitors, and evaluates the rational use of antimicrobials. Its broader purpose is to preserve the future effectiveness of these medicines while promoting and protecting public health.
Measuring Stewardship Impact
Important controversies remain about which antimicrobial-stewardship interventions are most effective. Questions also persist about how programmes should be designed and how their impact should be evaluated. Research priorities therefore include addressing the challenges faced by antibiotic and antifungal stewardship programmes.